SlideShare a Scribd company logo
CNS VASCULITIS
Dr Sankalp Mohan
Senior Resident
Neurology
GMC, Kota
VASCULITIS
 The vasculitides are defined by the presence
of inflammatory leukocytes in vessel walls
with reactive damage to mural structures.
 Compromise of the lumen leads to
downstream tissue ischemia and necrosis
 Pathogenetic mechanisms – immune
complex deposition , invasion of endothelial
cells by microorganisms , autoantibodies
,granuloma formation
CLASSIFICATION OF VASCULITIS
• Takayasu
• Giant Cell ArteritisLarge vessel
• PAN
• Kawasaki s disease
• Primary CNS vasculitis
Medium vessel
• Microscopic Polyangiitis
• Churg Strauss Syndrome
• Wegner s Granulomatosis
Small Vessel
CNS VASCULITIS
CLASSIFICATION
Primary angiitis of the CNS
(PACNS) when it is confined to
the CNS.
Secondary when associated
with various other disorders.
Reversible cerebral
vasoconstriction syndromes
PRIMARY CENTRAL NERVOUS SYSTEM
VASCULITIS (PACNS)
 . Defined as inflammation of the cerebral
vasculature without angiitis in other organs
 affects small- and medium-sized arteries of
the brain parenchyma, spinal cord, and
leptomeninges
 1. Granulomatous angiitis of the CNS
(GACNS)
 2. Atypical PACNS
GRANULOMATOUS ANGIITIS OF THE CENTRAL
NERVOUS SYSTEM
 20% of all patients with PACNS
 male-predominant (2:1)
 at any age mean age at diagnosis is 42
years,
 long prodromal period insidious onset of
symptoms
PATHOLOGY
 Langerhans or foreign body giant cells,
necrotizing vasculitis, or lymphocytic
vasculitis
 Atypical PACNS –biopsy is not
granulomatous , only lymphocytic infiltrate
 vessels to become narrowed, occluded and
thrombosed – ischemia
 In contrast to systemic vasculitides, the
finding of aneurysms in the cerebral arteries
is rare
PATHOGENESIS
 The cause of PACNS is unknown
 Infection — Infectious agents, particularly
mycoplasma and viruses
 varicella zoster virus, West Nile virus
 HIV infection can cause both a CNS
vasculitis and a CNS vasculopathy that is
associated with aneurysm formation
 Amyloid angiopathy
CLINICAL MANIFESTATIONS
 characterized by a long prodromal period
 Signs and symptoms of systemic vasculitis,
such as, fever, weight loss, or rash, are
usually lacking.
 highly variable and nonspecific
 PACNS should be suspected when strokes,
more often recurrent, occur in young patients
& unexplained diffuse neurologic dysfunction
 Decreased cognition — 83 percent
 Headache — 56 percent
 Seizure — 30 percent
 Stroke — 14 percent
 Cerebral hemorrhage — 12 percent
 Angiitis affecting the spinal cord usually
presents as a myelopathy /spinal cord
infarction
PROPOSED THE CRITERIA FOR THE DIAGNOSIS
OF PACNS.
 The presence of an acquired and otherwise
unexplained neurologic deficit and with
 (a) the presence of either classic angiographic or
histopathologic features of angiitis within the
CNS, and
 (b) no evidence of systemic vasculitis or any
condition that could elicit the angiographic or
pathologic features
DIAGNOSTIC TESTS
 erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP) are usually normal
 Serologic evaluation
 Antinuclear antibodies
 Rheumatoid factor
 Antibodies to the Ro/SSA, La/SSB, Sm, and RNP
antigens
 Antibodies to double-stranded DNA
 Antineutrophil cytoplasmic antibodies (ANCA)
 Serum C3 and C4
 Serum cryoglobulins
 Testing for infections appropriate to the
clinical circumstances
 Lumbar puncture –
 CSF is abnormal in 80 to 90 percent of
patients with pathologically documented
disease. There are no specific abnormalities
of the CSF in PACNS.
 excluding any infectious or malignant
process
 RCVS – CSF normal
NEUROIMAGING
 MR imaging =
 single or multiple, may include infarcts (both
white and gray matter) and hemorrhage, and
may be tumor-like
 Nonspecific high-intensity T2WI/FLAIR lesions
in white matter present in 42 percent of
Secondary vasculitis (low specificity )
 MR angiography — The resolution of MR
angiography (MRA) remains inadequate for the
demonstration of vasculitic changes
NEUROIMAGING
 Angiography
 positive findings if focal or diffuse areas of
arterial stenosis, occlusion, dilatation, or
beading were detected
 findings of ectasia and stenosis referred to as
"beading", usually in the small arteries
 sensitivity of angiography in biopsy proven
PACNS cases was only 60 percent
 Thus, a negative angiogram cannot be used to
exclude the diagnosis of PACNS.
 Brain and leptomeningeal biopsy
REVERSIBLE CEREBRAL VASOCONSTRICTION
SYNDROMES
 group of disorders linked by prolonged but
reversible vasoconstriction of the cerebral
arteries
 severe, acute-onset headaches
 Ischemic stroke and/or hemorrhage associated
with reperfusion may occur in the setting of
RCVS.
 pheochromocytoma and poorly-controlled
hypertension can also be associated with
cerebral vasospasm and clinical presentations
that mimic PACNS.
RCVS AND PACNS
 Symptom onset
 Clinical setting
 Reversibility of angiographic findings
 Cerebral spinal fluid (CSF)
SYSTEMIC VASCULITIS INVOLVING THE BRAIN
 systemic vasculitides,
 connective tissue disease (CTD),
sarcoidosis,
 infections,
 and lymphoproliferative diseases.
INFECTIOUS CAUSES
1. VZV -associated cerebral angiitis
 affects older age groups
 disease tends to be more localized
 Cerebral angiographic findings of segmental,
unilateral involvement of the vessels in the
distribution of the middle cerebral artery/ICA
 Diagnosis -higher antibodies levels of VZV in
the CSF than in the serum
 positive VZV PCR in the CSF
 (35%) of pathologic findings of AIDS-
associated CNS disease demonstrate
encephalitis, leptomeningitis, and/or
vasculitis,
Treponema pallidum – neurosyphilis
 most common in patients with HIV infections
 Meningitis and meningovascular disease are
the usual manifestation.
 May present as stroke
 CNS vasculitis associated with hepatitis C
virus (HCV) without underlying
cryoglobulinemia
SYSTEMIC VASCULITIDES AFFECTING CNS
 Temporal Arteritis
 Takayasu s Arteritis
 Wegener Granulomatosis
 Henoch Scholein Purpura
 Polyarteritis Nodosa
TEMPORAL ARTERITIS
 >50 years age .Women >men
 Transmural inflammation of arteries .intimal
hyperplasia
 Branches of ECA – sup temporal most common
 ICA ,Subclavian ,coronary and intracranial
 Systemic features fatigue, weight loss , anorexia
- Headche (new onset )unilateral localised to
areas of scalp ,Jaw claudication,scalp
tenderness
- -Neuropathy – Median nerve
- ,TIA and stroke
 Cranial neuropathies – AION .23 % of cases
 Temporary or permanent blindness
 Posterior ciliary arteritis
 Diagnosis – anemia ,High Esr ,CRP
 Angiography – stenotic segments or complet
occlusions
 Biopsy – Transmural inflammation,occlusion
 Sensitivity – 70 %
 Treatment – Prednisolone -40 -80 mg /day >high
dose for a month then taper .50% by one
month.1mg/month
POLYARTERITIS NODOSA
 Medium vessel vasculitis
 40 -60 yrs . Asso - Hep B,C ,cryoglobulinemia
 Inflammation of PMN, Monocytes – Fibrinoid necrosis
 Most common neurologic manifestation –
Mononeuritis multiplex
 CNS- 20 % - 40 %.diffuse encephalopathy ,focal
..infarcts in spinal cord ,brainstem.Rarely ICH,
 Optic neuropathy (AION)
 CNS abnormalities are late -after systemic signs and
PN
 Diagnosis – Clinical
 Multisystem involvement –Skin ,PN, Renal
,GIT
 Fever ,weight loss ,anemia raised ESR
 Angiography – may show saccular or
fusiform aneurysms
 Treatment – Systemic steroids with cytotoxic
agents – cyclophosphamide azthioprine
TAKAYASU S ARTERITIS
 10 -30 yrs of age .women more commonr ,fatigue ,anoreixa
 Aorta and its branches innominate,common carotid ,subclavian
,abdominal aorta ,celiac ,mesentric
Symptoms –
 Acute stage – low grade fever
 Stage of acute inflammation – Vascular Bruits ,diminished
pulses,hypertension
 Chronic phase- Claudication ,ischemic ulcers
Neurologic – Headche ,syncope blurred vision .
DIAGNOSIS –Arteriography – occlusion or dilatation/Stenosis
aneurysm of entire aorta or its primary branches
 TREATMENT – Prednisolone 1mg/kg /d for 3 months –taper
In unsuccesful cases cyclophosphamide ,MTX
WEGNER S GRANULOMATOSIS
 More in men 40 yrs
 Small and medium sized vessels
 Necrotizing granulomatous lesion in upper ,lower
respiratory tract , Kidneys
 50 % develop neurologic involvement
 Most have recurrent mononeuropathies,mononeuritis
multiplex, Cranial neuropathies II,VI,VII
 Ischemic stroke ,encephalopathy ,granulomatous
basilar meningitis , pachnymenigitis – less frequently
 Diagnosis –Clinical picture with c-ANCA
 Radiographically confirmed vasculitis of the
CNS in Wegener’s granulomatosis is rare,
because the small vessel
 MR findings – Dural thickening and
enhancement hyperintense brainstem
signals
 Treatment – corticosteroids plus
cyclophosphamide/azathioprine
BEHCET S DISEASE
 Oral ulcers ,Genital ulcers and Uveitis,Skin
finding ,(folliculitis and erythema nodosum
),Thrombophlebitis
 Neurologic involvement occurs in 6-10 %
CONNECTIVE TISSUE DISORDERS
 CTDs that can involve the CNS include
 Sjogren’s syndrome, rheumatoid arthritis,
mixed CTDs,
 and dermatomyositis
NEUROLOGIC MANIFESTATIONS OF SYSTEMIC
LUPUS ERYTHEMATOSUS
 seen in 10 to 80 percent of patients
 Direct involvement of CNS
 Secondary to complications of disease
/Treatment
 PATHOPHYSIOLOGY
 initially thought to be due to vasculitis.
 vasculopathy is characterized by a small to
moderate perivascular accumulation of
mononuclear cells, without destruction
 Accelerated atherosclerosis may contribute
to the risk of stroke
 Autoantibodies — The demonstration of a
number of autoantibodies including APLA
 Secondary factors — Prospective studies
suggest that from 50 to 78 percent of neurologic
episodes are caused by secondary factors
[ 2,35 ], including:
 Infections associated with immunosuppressive
therapy
 Metabolic complications of other organ system
failure, such as uremia
 Hypertension
 Toxic effects of therapy (particularly
corticosteroids)
COMMON CLINICAL SYNDROMES
REFERENCES
 CNS Vasculitis in Autoimmune Disease: MR Imaging
Findings and Correlation with Angiography --
AJNR 1999 20: 75-85
 Central nervous system vasculitis - Rula A. Hajj-Alia and
Leonard H. Calabreseb -, Cleveland Clinic, Cleveland, Ohio,
USA ; Current Opinion in Rheumatology 2009, 21:10–18
 Neurology Clinics –Neurology and systemic Disease . Feb
2010,vol28
 Caplan’s – Stroke –A clinical approach 4th edition ,Chapter
11-Non atherosclerotic vasculopathies
 www.uptodate.com

More Related Content

What's hot

Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitisNeurologyKota
 
Approach to myelopathy
Approach to myelopathy  Approach to myelopathy
Approach to myelopathy ikramdr01
 
CIDP recent advances
CIDP recent advances  CIDP recent advances
CIDP recent advances NeurologyKota
 
Non compressive myelopathy
Non compressive myelopathyNon compressive myelopathy
Non compressive myelopathyHirdesh Chawla
 
Autoimmune encephalitis current concepts
Autoimmune encephalitis current conceptsAutoimmune encephalitis current concepts
Autoimmune encephalitis current conceptsNeurologyKota
 
Approach to demyelinating diseases
Approach to demyelinating diseasesApproach to demyelinating diseases
Approach to demyelinating diseasesNeurologyKota
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalusNeurologyKota
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Ajay Kumar
 
Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy Ade Wijaya
 
Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome Ade Wijaya
 
Diffuse Axonal Injury
Diffuse Axonal Injury Diffuse Axonal Injury
Diffuse Axonal Injury Ade Wijaya
 

What's hot (20)

Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Autoimmune encephalitis
Autoimmune encephalitisAutoimmune encephalitis
Autoimmune encephalitis
 
Approach to myelopathy
Approach to myelopathy  Approach to myelopathy
Approach to myelopathy
 
CIDP recent advances
CIDP recent advances  CIDP recent advances
CIDP recent advances
 
Spinocerebellar ataxia
Spinocerebellar ataxiaSpinocerebellar ataxia
Spinocerebellar ataxia
 
Myelopathy 1
Myelopathy 1Myelopathy 1
Myelopathy 1
 
Approach to Ataxia
Approach to AtaxiaApproach to Ataxia
Approach to Ataxia
 
Non compressive myelopathy
Non compressive myelopathyNon compressive myelopathy
Non compressive myelopathy
 
Autoimmune encephalitis current concepts
Autoimmune encephalitis current conceptsAutoimmune encephalitis current concepts
Autoimmune encephalitis current concepts
 
Approach to demyelinating diseases
Approach to demyelinating diseasesApproach to demyelinating diseases
Approach to demyelinating diseases
 
Anterior cerebral circulation
Anterior cerebral circulationAnterior cerebral circulation
Anterior cerebral circulation
 
Refractory epilepsy
Refractory epilepsyRefractory epilepsy
Refractory epilepsy
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalus
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy
 
Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy
 
Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome Cerebral Salt Wasting Syndrome
Cerebral Salt Wasting Syndrome
 
Diffuse Axonal Injury
Diffuse Axonal Injury Diffuse Axonal Injury
Diffuse Axonal Injury
 
Nmosd & mog
Nmosd & mogNmosd & mog
Nmosd & mog
 
A Case of CIDP
A Case of CIDPA Case of CIDP
A Case of CIDP
 
Spinocerebellar ataxia
Spinocerebellar ataxiaSpinocerebellar ataxia
Spinocerebellar ataxia
 

Viewers also liked

Primary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challengesPrimary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challengesDiana Girnita
 
neurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisneurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisNeurology resident slides
 
Vasculitis and nervous system
Vasculitis and nervous systemVasculitis and nervous system
Vasculitis and nervous systemNeurologyKota
 
CNS vasculitis
CNS vasculitis CNS vasculitis
CNS vasculitis pkhohl
 
Vascular Malformations Of CNS Radiology
Vascular Malformations Of CNS RadiologyVascular Malformations Of CNS Radiology
Vascular Malformations Of CNS RadiologyRoshan Valentine
 
The Lonely Voices of Autoimmune Disease: Believe It or Not
The Lonely Voices of Autoimmune Disease: Believe It or NotThe Lonely Voices of Autoimmune Disease: Believe It or Not
The Lonely Voices of Autoimmune Disease: Believe It or NotDrBonnie360
 
Radiology of demyelinating diseases
Radiology of demyelinating diseases Radiology of demyelinating diseases
Radiology of demyelinating diseases NeurologyKota
 
Np resident lecture-wmdisease2009-slideshareupload
Np resident lecture-wmdisease2009-slideshareuploadNp resident lecture-wmdisease2009-slideshareupload
Np resident lecture-wmdisease2009-slideshareuploadcharleswhite3
 
Imaging of demyelinating diseases final
Imaging of demyelinating diseases finalImaging of demyelinating diseases final
Imaging of demyelinating diseases finalSunil Kumar
 
Imaging of cns viral infection
Imaging of cns viral infectionImaging of cns viral infection
Imaging of cns viral infectionNeurologyKota
 
CNS Imaging for Medical Students
CNS Imaging for Medical StudentsCNS Imaging for Medical Students
CNS Imaging for Medical StudentsMohd Ikhwan Chacho
 
nasim badarna - demyelinating disease
nasim badarna - demyelinating diseasenasim badarna - demyelinating disease
nasim badarna - demyelinating diseaseNaseem Badarna
 
Polypoidal Choroidal Vasculopathy
Polypoidal Choroidal VasculopathyPolypoidal Choroidal Vasculopathy
Polypoidal Choroidal Vasculopathymtodman
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system iiraj kumar
 
ANCA Associated Vasculitis - An Update 2014
ANCA Associated Vasculitis - An Update 2014ANCA Associated Vasculitis - An Update 2014
ANCA Associated Vasculitis - An Update 2014Richard McCrory
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathologyRaeez Basheer
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis Ahmed Bahnassy
 

Viewers also liked (20)

vasculitis
vasculitis vasculitis
vasculitis
 
Primary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challengesPrimary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challenges
 
neurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisneurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitis
 
Vasculitis and nervous system
Vasculitis and nervous systemVasculitis and nervous system
Vasculitis and nervous system
 
CNS vasculitis
CNS vasculitis CNS vasculitis
CNS vasculitis
 
Vascular Malformations Of CNS Radiology
Vascular Malformations Of CNS RadiologyVascular Malformations Of CNS Radiology
Vascular Malformations Of CNS Radiology
 
Patient Case Presentation
Patient Case PresentationPatient Case Presentation
Patient Case Presentation
 
The Lonely Voices of Autoimmune Disease: Believe It or Not
The Lonely Voices of Autoimmune Disease: Believe It or NotThe Lonely Voices of Autoimmune Disease: Believe It or Not
The Lonely Voices of Autoimmune Disease: Believe It or Not
 
Radiology of demyelinating diseases
Radiology of demyelinating diseases Radiology of demyelinating diseases
Radiology of demyelinating diseases
 
Np resident lecture-wmdisease2009-slideshareupload
Np resident lecture-wmdisease2009-slideshareuploadNp resident lecture-wmdisease2009-slideshareupload
Np resident lecture-wmdisease2009-slideshareupload
 
Imaging of demyelinating diseases final
Imaging of demyelinating diseases finalImaging of demyelinating diseases final
Imaging of demyelinating diseases final
 
Imaging of cns viral infection
Imaging of cns viral infectionImaging of cns viral infection
Imaging of cns viral infection
 
CNS Imaging for Medical Students
CNS Imaging for Medical StudentsCNS Imaging for Medical Students
CNS Imaging for Medical Students
 
nasim badarna - demyelinating disease
nasim badarna - demyelinating diseasenasim badarna - demyelinating disease
nasim badarna - demyelinating disease
 
Polypoidal Choroidal Vasculopathy
Polypoidal Choroidal VasculopathyPolypoidal Choroidal Vasculopathy
Polypoidal Choroidal Vasculopathy
 
Anca talk
Anca talkAnca talk
Anca talk
 
The central nervous system ii
The central nervous system iiThe central nervous system ii
The central nervous system ii
 
ANCA Associated Vasculitis - An Update 2014
ANCA Associated Vasculitis - An Update 2014ANCA Associated Vasculitis - An Update 2014
ANCA Associated Vasculitis - An Update 2014
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
 

Similar to Cns vasculitis

Primary CNS vasculitis
Primary CNS vasculitisPrimary CNS vasculitis
Primary CNS vasculitisYasser Alzainy
 
Neurological manisfestation of pri vasculitis syndrome
Neurological manisfestation of pri vasculitis syndromeNeurological manisfestation of pri vasculitis syndrome
Neurological manisfestation of pri vasculitis syndromeNeurologyKota
 
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptx
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptxPOSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptx
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptxGopiKrishnanR11
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxhussainAltaher
 
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROMEPOSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROMEGovindRankawat1
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeSAYED FATHY
 
Vascular brain lesions for radiology by Dr Soumitra Halder
Vascular brain lesions for radiology by Dr Soumitra HalderVascular brain lesions for radiology by Dr Soumitra Halder
Vascular brain lesions for radiology by Dr Soumitra HalderSoumitra Halder
 
Imaging in stroke
Imaging in stroke Imaging in stroke
Imaging in stroke Deepak Garg
 
Aneurysm
AneurysmAneurysm
Aneurysmasalim4
 
Vasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatmentVasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatmentSachin Verma
 
Vasospasm in subarachnoid haemorrhage pre finale
Vasospasm in subarachnoid haemorrhage pre finaleVasospasm in subarachnoid haemorrhage pre finale
Vasospasm in subarachnoid haemorrhage pre finaleDr Fakir Mohan Sahu
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMAnass Qasem
 
Painful Ophthalmoplegia
Painful Ophthalmoplegia   Painful Ophthalmoplegia
Painful Ophthalmoplegia Junaid Naina
 

Similar to Cns vasculitis (20)

Primary CNS vasculitis
Primary CNS vasculitisPrimary CNS vasculitis
Primary CNS vasculitis
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Neurological manisfestation of pri vasculitis syndrome
Neurological manisfestation of pri vasculitis syndromeNeurological manisfestation of pri vasculitis syndrome
Neurological manisfestation of pri vasculitis syndrome
 
Primary cns vasculitis
Primary cns vasculitisPrimary cns vasculitis
Primary cns vasculitis
 
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptx
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptxPOSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptx
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES).pptx
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
 
Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.
 
Vasculitis 2015 undergraduate
Vasculitis 2015 undergraduateVasculitis 2015 undergraduate
Vasculitis 2015 undergraduate
 
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROMEPOSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndrome
 
Vascular brain lesions for radiology by Dr Soumitra Halder
Vascular brain lesions for radiology by Dr Soumitra HalderVascular brain lesions for radiology by Dr Soumitra Halder
Vascular brain lesions for radiology by Dr Soumitra Halder
 
Imaging in stroke
Imaging in stroke Imaging in stroke
Imaging in stroke
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
Neurocysticercosis
NeurocysticercosisNeurocysticercosis
Neurocysticercosis
 
Vasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatmentVasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatment
 
Nph
NphNph
Nph
 
Vasospasm in subarachnoid haemorrhage pre finale
Vasospasm in subarachnoid haemorrhage pre finaleVasospasm in subarachnoid haemorrhage pre finale
Vasospasm in subarachnoid haemorrhage pre finale
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBM
 
Vasculitis.pdf
Vasculitis.pdfVasculitis.pdf
Vasculitis.pdf
 
Painful Ophthalmoplegia
Painful Ophthalmoplegia   Painful Ophthalmoplegia
Painful Ophthalmoplegia
 

More from NeurologyKota

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxNeurologyKota
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNeurologyKota
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxNeurologyKota
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxNeurologyKota
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxNeurologyKota
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxNeurologyKota
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxNeurologyKota
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxNeurologyKota
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxNeurologyKota
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY NeurologyKota
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxNeurologyKota
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptxNeurologyKota
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NeurologyKota
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxNeurologyKota
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxNeurologyKota
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxNeurologyKota
 

More from NeurologyKota (20)

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptx
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
 
REMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptxREMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptx
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptx
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
 
CAROTID WEB.pptx
CAROTID WEB.pptxCAROTID WEB.pptx
CAROTID WEB.pptx
 
CNS IRIS.pptx
CNS IRIS.pptxCNS IRIS.pptx
CNS IRIS.pptx
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptx
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptx
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptx
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptx
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptx
 

Recently uploaded

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfSasikiranMarri
 
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...aunty1x1
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........TheDocs
 
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
 
Enhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfEnhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfgajendrasinh1303
 
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxStorage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxBariquins
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxBlake100757
 
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfCHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfSachin Sharma
 
Valle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseValle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseKristin Hetzer
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfSachin Sharma
 
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model SafeJaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safeaunty1x1
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxrenewlifehypnosis
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisonersAhmed Elmi
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfVirtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfsmartcare
 

Recently uploaded (20)

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
Enhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfEnhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdf
 
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxStorage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfCHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
 
Valle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseValle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder Abuse
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
 
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model SafeJaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
 
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdfVirtual Health Platforms_ Revolutionizing Patient Care.pdf
Virtual Health Platforms_ Revolutionizing Patient Care.pdf
 

Cns vasculitis

  • 1. CNS VASCULITIS Dr Sankalp Mohan Senior Resident Neurology GMC, Kota
  • 2. VASCULITIS  The vasculitides are defined by the presence of inflammatory leukocytes in vessel walls with reactive damage to mural structures.  Compromise of the lumen leads to downstream tissue ischemia and necrosis  Pathogenetic mechanisms – immune complex deposition , invasion of endothelial cells by microorganisms , autoantibodies ,granuloma formation
  • 3. CLASSIFICATION OF VASCULITIS • Takayasu • Giant Cell ArteritisLarge vessel • PAN • Kawasaki s disease • Primary CNS vasculitis Medium vessel • Microscopic Polyangiitis • Churg Strauss Syndrome • Wegner s Granulomatosis Small Vessel
  • 5. CLASSIFICATION Primary angiitis of the CNS (PACNS) when it is confined to the CNS. Secondary when associated with various other disorders. Reversible cerebral vasoconstriction syndromes
  • 6. PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS (PACNS)  . Defined as inflammation of the cerebral vasculature without angiitis in other organs  affects small- and medium-sized arteries of the brain parenchyma, spinal cord, and leptomeninges  1. Granulomatous angiitis of the CNS (GACNS)  2. Atypical PACNS
  • 7. GRANULOMATOUS ANGIITIS OF THE CENTRAL NERVOUS SYSTEM  20% of all patients with PACNS  male-predominant (2:1)  at any age mean age at diagnosis is 42 years,  long prodromal period insidious onset of symptoms
  • 8. PATHOLOGY  Langerhans or foreign body giant cells, necrotizing vasculitis, or lymphocytic vasculitis  Atypical PACNS –biopsy is not granulomatous , only lymphocytic infiltrate  vessels to become narrowed, occluded and thrombosed – ischemia  In contrast to systemic vasculitides, the finding of aneurysms in the cerebral arteries is rare
  • 9. PATHOGENESIS  The cause of PACNS is unknown  Infection — Infectious agents, particularly mycoplasma and viruses  varicella zoster virus, West Nile virus  HIV infection can cause both a CNS vasculitis and a CNS vasculopathy that is associated with aneurysm formation  Amyloid angiopathy
  • 10. CLINICAL MANIFESTATIONS  characterized by a long prodromal period  Signs and symptoms of systemic vasculitis, such as, fever, weight loss, or rash, are usually lacking.  highly variable and nonspecific  PACNS should be suspected when strokes, more often recurrent, occur in young patients & unexplained diffuse neurologic dysfunction
  • 11.  Decreased cognition — 83 percent  Headache — 56 percent  Seizure — 30 percent  Stroke — 14 percent  Cerebral hemorrhage — 12 percent  Angiitis affecting the spinal cord usually presents as a myelopathy /spinal cord infarction
  • 12. PROPOSED THE CRITERIA FOR THE DIAGNOSIS OF PACNS.  The presence of an acquired and otherwise unexplained neurologic deficit and with  (a) the presence of either classic angiographic or histopathologic features of angiitis within the CNS, and  (b) no evidence of systemic vasculitis or any condition that could elicit the angiographic or pathologic features
  • 13. DIAGNOSTIC TESTS  erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) are usually normal  Serologic evaluation  Antinuclear antibodies  Rheumatoid factor  Antibodies to the Ro/SSA, La/SSB, Sm, and RNP antigens  Antibodies to double-stranded DNA  Antineutrophil cytoplasmic antibodies (ANCA)  Serum C3 and C4  Serum cryoglobulins
  • 14.  Testing for infections appropriate to the clinical circumstances  Lumbar puncture –  CSF is abnormal in 80 to 90 percent of patients with pathologically documented disease. There are no specific abnormalities of the CSF in PACNS.  excluding any infectious or malignant process  RCVS – CSF normal
  • 15. NEUROIMAGING  MR imaging =  single or multiple, may include infarcts (both white and gray matter) and hemorrhage, and may be tumor-like  Nonspecific high-intensity T2WI/FLAIR lesions in white matter present in 42 percent of Secondary vasculitis (low specificity )  MR angiography — The resolution of MR angiography (MRA) remains inadequate for the demonstration of vasculitic changes
  • 16. NEUROIMAGING  Angiography  positive findings if focal or diffuse areas of arterial stenosis, occlusion, dilatation, or beading were detected  findings of ectasia and stenosis referred to as "beading", usually in the small arteries  sensitivity of angiography in biopsy proven PACNS cases was only 60 percent  Thus, a negative angiogram cannot be used to exclude the diagnosis of PACNS.
  • 17.  Brain and leptomeningeal biopsy
  • 18.
  • 19.
  • 20.
  • 21. REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROMES  group of disorders linked by prolonged but reversible vasoconstriction of the cerebral arteries  severe, acute-onset headaches  Ischemic stroke and/or hemorrhage associated with reperfusion may occur in the setting of RCVS.  pheochromocytoma and poorly-controlled hypertension can also be associated with cerebral vasospasm and clinical presentations that mimic PACNS.
  • 22. RCVS AND PACNS  Symptom onset  Clinical setting  Reversibility of angiographic findings  Cerebral spinal fluid (CSF)
  • 23. SYSTEMIC VASCULITIS INVOLVING THE BRAIN  systemic vasculitides,  connective tissue disease (CTD), sarcoidosis,  infections,  and lymphoproliferative diseases.
  • 24. INFECTIOUS CAUSES 1. VZV -associated cerebral angiitis  affects older age groups  disease tends to be more localized  Cerebral angiographic findings of segmental, unilateral involvement of the vessels in the distribution of the middle cerebral artery/ICA  Diagnosis -higher antibodies levels of VZV in the CSF than in the serum  positive VZV PCR in the CSF
  • 25.  (35%) of pathologic findings of AIDS- associated CNS disease demonstrate encephalitis, leptomeningitis, and/or vasculitis, Treponema pallidum – neurosyphilis  most common in patients with HIV infections  Meningitis and meningovascular disease are the usual manifestation.  May present as stroke
  • 26.  CNS vasculitis associated with hepatitis C virus (HCV) without underlying cryoglobulinemia
  • 27. SYSTEMIC VASCULITIDES AFFECTING CNS  Temporal Arteritis  Takayasu s Arteritis  Wegener Granulomatosis  Henoch Scholein Purpura  Polyarteritis Nodosa
  • 28. TEMPORAL ARTERITIS  >50 years age .Women >men  Transmural inflammation of arteries .intimal hyperplasia  Branches of ECA – sup temporal most common  ICA ,Subclavian ,coronary and intracranial  Systemic features fatigue, weight loss , anorexia - Headche (new onset )unilateral localised to areas of scalp ,Jaw claudication,scalp tenderness - -Neuropathy – Median nerve - ,TIA and stroke
  • 29.  Cranial neuropathies – AION .23 % of cases  Temporary or permanent blindness  Posterior ciliary arteritis  Diagnosis – anemia ,High Esr ,CRP  Angiography – stenotic segments or complet occlusions  Biopsy – Transmural inflammation,occlusion  Sensitivity – 70 %  Treatment – Prednisolone -40 -80 mg /day >high dose for a month then taper .50% by one month.1mg/month
  • 30. POLYARTERITIS NODOSA  Medium vessel vasculitis  40 -60 yrs . Asso - Hep B,C ,cryoglobulinemia  Inflammation of PMN, Monocytes – Fibrinoid necrosis  Most common neurologic manifestation – Mononeuritis multiplex  CNS- 20 % - 40 %.diffuse encephalopathy ,focal ..infarcts in spinal cord ,brainstem.Rarely ICH,  Optic neuropathy (AION)  CNS abnormalities are late -after systemic signs and PN
  • 31.  Diagnosis – Clinical  Multisystem involvement –Skin ,PN, Renal ,GIT  Fever ,weight loss ,anemia raised ESR  Angiography – may show saccular or fusiform aneurysms  Treatment – Systemic steroids with cytotoxic agents – cyclophosphamide azthioprine
  • 32. TAKAYASU S ARTERITIS  10 -30 yrs of age .women more commonr ,fatigue ,anoreixa  Aorta and its branches innominate,common carotid ,subclavian ,abdominal aorta ,celiac ,mesentric Symptoms –  Acute stage – low grade fever  Stage of acute inflammation – Vascular Bruits ,diminished pulses,hypertension  Chronic phase- Claudication ,ischemic ulcers Neurologic – Headche ,syncope blurred vision . DIAGNOSIS –Arteriography – occlusion or dilatation/Stenosis aneurysm of entire aorta or its primary branches  TREATMENT – Prednisolone 1mg/kg /d for 3 months –taper In unsuccesful cases cyclophosphamide ,MTX
  • 33. WEGNER S GRANULOMATOSIS  More in men 40 yrs  Small and medium sized vessels  Necrotizing granulomatous lesion in upper ,lower respiratory tract , Kidneys  50 % develop neurologic involvement  Most have recurrent mononeuropathies,mononeuritis multiplex, Cranial neuropathies II,VI,VII  Ischemic stroke ,encephalopathy ,granulomatous basilar meningitis , pachnymenigitis – less frequently
  • 34.  Diagnosis –Clinical picture with c-ANCA  Radiographically confirmed vasculitis of the CNS in Wegener’s granulomatosis is rare, because the small vessel  MR findings – Dural thickening and enhancement hyperintense brainstem signals  Treatment – corticosteroids plus cyclophosphamide/azathioprine
  • 35. BEHCET S DISEASE  Oral ulcers ,Genital ulcers and Uveitis,Skin finding ,(folliculitis and erythema nodosum ),Thrombophlebitis  Neurologic involvement occurs in 6-10 %
  • 36. CONNECTIVE TISSUE DISORDERS  CTDs that can involve the CNS include  Sjogren’s syndrome, rheumatoid arthritis, mixed CTDs,  and dermatomyositis
  • 37. NEUROLOGIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS  seen in 10 to 80 percent of patients  Direct involvement of CNS  Secondary to complications of disease /Treatment
  • 38.  PATHOPHYSIOLOGY  initially thought to be due to vasculitis.  vasculopathy is characterized by a small to moderate perivascular accumulation of mononuclear cells, without destruction  Accelerated atherosclerosis may contribute to the risk of stroke  Autoantibodies — The demonstration of a number of autoantibodies including APLA
  • 39.  Secondary factors — Prospective studies suggest that from 50 to 78 percent of neurologic episodes are caused by secondary factors [ 2,35 ], including:  Infections associated with immunosuppressive therapy  Metabolic complications of other organ system failure, such as uremia  Hypertension  Toxic effects of therapy (particularly corticosteroids)
  • 41. REFERENCES  CNS Vasculitis in Autoimmune Disease: MR Imaging Findings and Correlation with Angiography -- AJNR 1999 20: 75-85  Central nervous system vasculitis - Rula A. Hajj-Alia and Leonard H. Calabreseb -, Cleveland Clinic, Cleveland, Ohio, USA ; Current Opinion in Rheumatology 2009, 21:10–18  Neurology Clinics –Neurology and systemic Disease . Feb 2010,vol28  Caplan’s – Stroke –A clinical approach 4th edition ,Chapter 11-Non atherosclerotic vasculopathies  www.uptodate.com